Category: Expert Interviews

Related News

Natural Resource-Related Stocks Show Promise: Frank Barbera

Article Picture The Gold Report: Europe is in the headlines daily: more leftists coming to power, regional banks suffering, renewed recession appearing to take hold. What is your take on Europe? Frank Barbera: In the headlines, Europe looks like quite the mess. Imagine being a Greek who saved over a lifetime now facing the possibility of devaluation or Greece leaving the euro.

The People Have Spoken and Precious Metals Will Soar: Leonard Melman

Article Picture TGR: It seems that economists can plan and recommend, and politicians can negotiate and maneuver, and pundits can analyze and predict all they want, yet when the people don't want to play along, it can all mean nothing. Of course, we're talking about the elections in France and Greece.

The Recovery Is an Illusion: John Williams

Article Picture The Gold Report: John, at the recent Casey Research Recovery Reality Check conference you described the economic recovery heralded by the Obama administration as an illusion based largely on skewed inflation data. Can you walk us through why, based on your calculations, a recovery is impossible? John Williams: We can start with the gross domestic product (GDP), which like most economic reports is adjusted for inflation.

An Extraordinary Time to Be in the Driver’s Seat: Aaron Kennon

Article Picture The Gold Report: Clear Harbor Asset Management actively invests in resource equities, and it's doing so during one of the most bearish periods ever for resource equities, particularly for small-cap resource equities. Some institutions are leaving the space altogether while others are reducing their exposure. What are your plans? Aaron Kennon: While the resource benchmarks have all suffered significantly over the last several years, Clear Harbor's natural resources strategy has returned more than 58% since inception 27 months ago.

Five Companies in the Casey Portfolio Worth Watching: Alex Daley

Article Picture The Life Sciences Report: How do you find the companies that you recommend?Alex Daley: We look for the science first. There are a lot of companies in the biotechnology field. Some pin the number at more than 7,000 biotech companies, public and private, in the U.S. alone. That is a lot of data to sort through. The sector possesses a great mix of hype and expectations, which can bewilder investors at times.

Recovery Via Shared Sacrifice: Lacy Hunt

Article Picture The Gold Report: In January, the Federal Reserve's extension of a near-zero rate interest policy to the end of 2014 stunned a good many investors. Unless the Fed changes its mind again, that will mean six years of artificially low rates. You've indicated that interest rates have nothing to do with the Fed and that they're really governed by the velocity of money and the health of the economy.

Bob Moriarty: A Contrarian’s Guide to Volatile Markets

Article Picture The Gold Report: We're hearing many people these days warning that it's not a good time for investing in junior mining stocks. The TSX Venture Exchange has been experiencing some of its lowest volumes in six to nine months. What do you believe investors should do this summer? Bob Moriarty: Anybody following my website for years will be familiar with me saying this: You can ignore technical analysis. You can ignore seasonality. You can ignore fundamentals.

Gold Is Not a Growth Industry—It Can Just Pay Investors Big: John Hathaway

Article Picture The Gold Report: When we spoke last October, you were bullish on gold and gold equities. You blamed lagging gold‐mining stock performance on competition from exchange‐traded funds (ETF), lack of investor confidence and investor doubts on the sustainability of higher gold prices. Now that prices are hovering around $1,600 an ounce (oz), will that dynamic change? John Hathaway: The dynamic will change based on higher gold prices. When one looks at Newmont Mining Corp.

Will Mayo v. Prometheus Fire Up Pharma?: Kevin DeGeeter

Article Picture The Life Sciences Report: You are focused on personalized medicine. On March 20, the U.S. Supreme Court ruling in Mayo Collaborative Services Inc. v. Prometheus Laboratories was handed down. At issue was whether using a diagnostic test to adjust a drug dosing regimen could be patented. The decision was unanimous in favor of Mayo Foundation for Medical Education and Research (nonprofit) on the grounds that a company cannot patent laws of nature.

Recent News

  • Natural Resource-Related Stocks Show Promise: Frank Barbera

    The Gold Report: Europe is in the headlines daily: more leftists coming to power, regional banks suffering, renewed recession appearing to take hold. What is your take on Europe?

    Frank Barbera: In the headlines, Europe looks like quite the mess. Imagine being a Greek who saved over a lifetime now facing the possibility of devaluation or Greece leaving the euro. If Greece pulls out of the euro and devalues, most of the people will see their life savings collapse in terms of purchasing power.

    In my view, there is a pretty good chance that would spark a contagion. When people in Spain or Italy see Greece pull out and return to a devalued drachma, there will be . . . → Read More: Natural Resource-Related Stocks Show Promise: Frank Barbera

  • Natural Resource-Related Stocks Show Promise: Frank Barbera

    The Gold Report: Europe is in the headlines daily: more leftists coming to power, regional banks suffering, renewed recession appearing to take hold. What is your take on Europe?

    Frank Barbera: In the headlines, Europe looks like quite the mess. Imagine being a Greek who saved over a lifetime now facing the possibility of devaluation or Greece leaving the euro. If Greece pulls out of the euro and devalues, most of the people will see their life savings collapse in terms of purchasing power.

    In my view, there is a pretty good chance that would spark a contagion. When people in Spain or Italy see Greece pull out and return to a devalued drachma, there will be . . . → Read More: Natural Resource-Related Stocks Show Promise: Frank Barbera

  • Dr. Frankenstein’s Europe

    "Had I right, for my own benefit, to inflict this curse upon everlasting generations? I had before been moved by the sophisms of the being I had created; I had been struck senseless by his fiendish threats; but now, for the first time, the wickedness of my promise burst upon me; I shuddered to think that future ages might curse me as their pest, whose selfishness had not hesitated to buy its own peace at the price, perhaps, of the existence of the whole human race."

    – The musings of Dr. Frankenstein about his creation of a monster, in Mary Shelley’s 1818 novel, Frankenstein

    And later the monster answers:

    "Shall each man," cried he, "find a wife for his . . . → Read More: Dr. Frankenstein’s Europe

  • The People Have Spoken and Precious Metals Will Soar: Leonard Melman

    TGR: It seems that economists can plan and recommend, and politicians can negotiate and maneuver, and pundits can analyze and predict all they want, yet when the people don’t want to play along, it can all mean nothing. Of course, we’re talking about the elections in France and Greece. What’s going on?

    Leonard Melman: What’s going on is that the monetary authorities in Europe have decided that austerity is the only way out of the financial dilemma, which I find kind of amusing, because it is their Keynesian activities that created those policies in the first place. Their decision now is that austerity, which is cutting back government programs, is the only thing that will work. The problem is . . . → Read More: The People Have Spoken and Precious Metals Will Soar: Leonard Melman

  • Are JPMorgan Chase ETNs Safe?

    I don’t know about you, but here in Texas I can barely drive a mile without passing a JPMorgan Chase (JPM) branch. They’re even inside the grocery stores.

    Simply being everywhere doesn’t make a bank safe, of course. As we learned last week, traders in London just cost JPMorgan $2 BILLION and possibly more! Fitch Ratings downgraded its credit rating one notch to A-plus, and it looks like Moody’s may cut the bank, too.

    Weiss Ratings, ahead of the curve as usual, cut JPMorgan Chase to “D” on September 30, 2010. And on October 22, 2010, they issued a special news release advising subscribers that among U.S. banks, JPMorgan was carrying the largest . . . → Read More: Are JPMorgan Chase ETNs Safe?
 
  Older Entries »

Also in the news